Noel W. Clarke
University of Manchester(GB)Salford Royal Hospital(GB)Cancer Research UK Manchester Institute(GB)The Christie Hospital(GB)The Christie NHS Foundation Trust(GB)
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer, Lipids, and Metabolism, Radiopharmaceutical Chemistry and Applications, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial(2015)1,944 cited
- → Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy(2017)1,740 cited
- → Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial(2018)1,234 cited
- → Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017(2017)639 cited
- → Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)(2014)433 cited
- → Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer